A new study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children’s Hospital Los Angeles, shows evidence of dysfunction of the blood–brain barrier and inflammation in the central nervous system in individuals with Down syndrome regression disorder (DSRD).
Leave A Comment